Literature DB >> 12562485

Comparison of fentanyl-bupivacaine or midazolam-bupivacaine mixtures with plain bupivacaine for caudal anaesthesia in children.

Sibel Baris1, Deniz Karakaya, Ebru Kelsaka, Fuat Güldogus, Ender Ariturk, Ayla Tür.   

Abstract

BACKGROUND: The aim of this study was to evaluate the intensity and effectiveness of 0.75 ml.kg-1 bupivacaine 0.25% with the addition of fentanyl or midazolam for caudal block in children undergoing inguinal herniorrhaphy.
METHODS: Seventy-five children were allocated randomly to three groups to receive a caudal block with either 0.25% bupivacaine with fentanyl 1 microg.kg(-1) (group BF) or with midazolam 50 microg.kg(-1) (group BM) or bupivacaine alone (group B) after induction of anaesthesia. Haemodynamic parameters, degree of pain, additional analgesic requirements and side-effects were evaluated.
RESULTS: The mean systolic arterial pressure at 10, 20, 30 min after caudal block was higher in group B compared with groups BF and BM. Mean intraoperative heart rate was lower in group BF than the other groups. Adequate analgesia was obtained in all patients (100%) in group BF, 23 patients (92%) in group BM and 21 patients (84%) in group B (P > 0.05). The time to recovery to an Aldrete score of 10 was significantly shorter in group B than group BM (P < 0.05). Although not significant, it was also shorter in group B than group BF. There was no difference in additional analgesic requirements between the groups in the first 24 h. Sedation score was higher in the midazolam group at 60 and 90 min postoperatively than the other groups.
CONCLUSIONS: Caudal block with 0.75 ml.kg(-1) 0.25% bupivacaine and 50 microg.kg(-1) midazolam or 1 microg.kg(-1) fentanyl provides no further analgesic advantages to bupivacaine alone when administered immediately after induction of anaesthesia in children undergoing unilateral inguinal herniorrhaphy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12562485     DOI: 10.1046/j.1460-9592.2003.00979.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  7 in total

Review 1.  Neuraxial analgesia in neonates and infants: a review of clinical and preclinical strategies for the development of safety and efficacy data.

Authors:  Suellen M Walker; Tony L Yaksh
Journal:  Anesth Analg       Date:  2012-07-13       Impact factor: 5.108

2.  Effect of intrathecal midazolam in the severity of pain in cesarean section: a randomized controlled trail.

Authors:  A Karbasfrushan; K Farhadi; J Amini-Saman; S Bazargan-Hejazi; A Ahmadi
Journal:  Iran Red Crescent Med J       Date:  2012-05-30       Impact factor: 0.611

3.  The success rate and complications of awake caudal epidural bupivacaine alone or in combination with intravenous midazolam and ketamine in pre-term infants.

Authors:  Mahin Seyedhejazi; Majed Mashhoori; Rasoul Azarfarin; Daryoush Shekhzadeh; Nasrin Taghizadieh
Journal:  Afr J Paediatr Surg       Date:  2015 Oct-Dec

4.  Treatment of Postoperative Pain in Pediatric Operations: Comparing the Efficiency of Bupivacaine, Bupivacaine-Dexmedetomidine and Bupivacaine-Fentanyl for Caudal Block.

Authors:  Hashem Jarineshin; Fereydoon Fekrat; Aida Kargar Kermanshah
Journal:  Anesth Pain Med       Date:  2016-07-26

5.  Effect of Addition of Fentanyl and Clonidine to Local Anesthetic Solution in Peribulbar Block.

Authors:  Poonam Nehra; Vrinda Oza; Vandana Parmar; Pooja Fumakiya
Journal:  J Pharmacol Pharmacother       Date:  2017 Jan-Mar

6.  Efficacy of Adding Midazolam to Bupivacaine for Transversus Abdominis Plane Block on Postoperative Analgesia after Hysterectomy: A Randomized Controlled Study.

Authors:  Samah El Kenany; Mohamed Eslam Elshehawi; Ahmed Mohamed Farid; Mohamed Ibrahem Eid
Journal:  Anesth Essays Res       Date:  2019 Jul-Sep

7.  A randomized-controlled, double-blind study to evaluate the efficacy of caudal midazolam, ketamine and neostigmine as adjuvants to bupivacaine on postoperative analgesic in children undergoing lower abdominal surgery.

Authors:  Musa Shirmohammadie; Alireza Ebrahim Soltani; Shahriar Arbabi; Karim Nasseri
Journal:  Acta Biomed       Date:  2019-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.